Jiangsu Jumpcan Pharmaceutical Group Co Ltd (600566):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Jiangsu Jumpcan Pharmaceutical Group Co Ltd (600566) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9435
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Jiangsu Jumpcan Pharmaceutical Group Co Ltd (Jiangsu Jumpcan Pharma) is a developer, manufacturer and distributor of Chinese traditional medicine, Western medicine, daily use chemicals and healthcare products. The company offers its products in various therapeutic segments such as detoxification, digestive system, pediatric, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, hemostasis, gynecology, pneumology, gastroenterology and geriatrics, among others. It provides its products in the form of tablets, capsules, oral liquid, oral solution, injections, syrups, powder, ointment, spray and others. The company sells its products throughout China. Jiangsu Jumpcan Pharma is headquartered in Taixing, China.

Jiangsu Jumpcan Pharmaceutical Group Co Ltd (600566) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Hubei Jumpcan Pharma Raises USD98.3 Million Private Placement of Shares 10
Hubei Jumpcan Pharma Raises USD98.3 Million in Private Placement of Shares 11
Debt Offering 13
Hubei Jumpcan Pharma Decreases Size of Public Offering of Bonds for USD122 Million 13
Jiangsu Jumpcan Pharmaceutical Group Co Ltd – Key Competitors 14
Jiangsu Jumpcan Pharmaceutical Group Co Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hubei Jumpcan Pharma Raises USD98.3 Million Private Placement of Shares 10
Hubei Jumpcan Pharma Raises USD98.3 Million in Private Placement of Shares 11
Hubei Jumpcan Pharma Decreases Size of Public Offering of Bonds for USD122 Million 13
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Key Competitors 14

List of Figures
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jiangsu Jumpcan Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Jiangsu Jumpcan Pharmaceutical Group Co Ltd (600566):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genomind Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing services. The company offers Genecept Assay, a pharmacogenetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. Its test is used to guide treatment fo …
  • Ingram Micro Inc.:企業のM&A・事業提携・投資動向
    Ingram Micro Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ingram Micro Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Accent Resources N.L.:企業の戦略・SWOT・財務情報
    Accent Resources N.L. - Strategy, SWOT and Corporate Finance Report Summary Accent Resources N.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Calumet Specialty Products Partners, L.P.:企業の戦略・SWOT・財務分析
    Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Johnson & Johnson (JNJ)-医療機器分野:企業M&A・提携分析
    Summary Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infec …
  • Banco do Brasil SA:戦略・SWOT・企業財務分析
    Banco do Brasil SA - Strategy, SWOT and Corporate Finance Report Summary Banco do Brasil SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Verisante Technology Inc:医療機器:M&Aディール及び事業提携情報
    Summary Verisante Technology Inc (Verisante) is a medical device company that develops and commercializes systems for the early detection of cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detecti …
  • PetroChina Co Ltd (857)-エネルギー分野:企業M&A・提携分析
    Summary PetroChina Company Limited (PetroChina), a subsidiary of China National Petroleum Corporation, is an oil and gas company that explores for, develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical products …
  • Plansee Holding AG:企業の戦略・SWOT・財務分析
    Plansee Holding AG - Strategy, SWOT and Corporate Finance Report Summary Plansee Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Toyota Tsusho Corporation (8015):企業の財務・戦略的SWOT分析
    Toyota Tsusho Corporation (8015) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Relmada Therapeutics Inc (RLMD):製薬・医療:M&Aディール及び事業提携情報
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Odonate Therapeutics Inc (ODT):製薬・医療:M&Aディール及び事業提携情報
    Summary Odonate Therapeutics Inc (Odonate), formerly Odonate Therapeutics LLC, is a pharmaceutical company that develops medicines for the treatment of cancer. The company provides product candidate, tesetaxel which is a novel orally administered taxane used for the treatment of advanced and metasta …
  • Advicenne SA (ADVIC)-製薬・医療分野:企業M&A・提携分析
    Summary Advicenne SA (Advicenne) is a developer of pediatric medicines. The company’s product portfolio includes ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It offer …
  • Photocure ASA (PHO):企業の財務・戦略的SWOT分析
    Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • PT Charoen Pokphand Indonesia Tbk (CPIN):企業の財務・戦略的SWOT分析
    PT Charoen Pokphand Indonesia Tbk (CPIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • IXICO Plc (IXI):医療機器:M&Aディール及び事業提携情報
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as assessa, trial tracker, trialwire and mehealth. It provides web-based …
  • Tesco Corporation:戦略・SWOT・企業財務分析
    Tesco Corporation - Strategy, SWOT and Corporate Finance Report Summary Tesco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Great Portland Estates Plc (GPOR):企業の財務・戦略的SWOT分析
    Great Portland Estates Plc (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Flex Foods Ltd:企業の戦略・SWOT・財務情報
    Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Techno – Agricultural Supplying (TSC):企業の財務・戦略的SWOT分析
    Techno - Agricultural Supplying (TSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆